The purpose of this study is to assess risk for HPV driven oropharyngeal cancers by using HPV blood tests and clinical features (such as tumor stage and smokin…

HPV-positive Oropharyngeal Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma

~Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT07513324

Phase 2

The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)

The purpose of this study is to determine whether treatment of HPV-related oropharyngeal squamous cell carcinoma in patients with undetectable postoperative HP…

HPV-positive Oropharyngeal Squamous Cell Carcinoma

~Estimated

~$10 – $6,250

Icahn School of Medicine at Mount SinaiNCT05419089